32
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Angiotensin-converting-enzyme gene polymorphism and heart failure: a case–control study

, , , , , , & show all
Pages 429-436 | Received 24 Apr 2003, Accepted 16 Jun 2003, Published online: 04 Oct 2008

References

  • ABRAHAM, M. R, OLSON, L. J., JOYNER, J., TURNER, S. T., BECK, K C. and JOHNSON, B. D. 2002, Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation, 106, 1794–1799.
  • ANDERSON, J. L., CARLQTJIST, J. F., GRETCHEN, J. K., MORRISON, L., THOMSON, M. J., LTJDWIG, E. H., MUHLESTEIN, J. B., BAIR, T. L and WARD, R H. 1998, Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women. Journal of the American College of Cardiology, 31, 790–796.
  • CAMBIEN, F., POIRIER, 0., LECERF, L., EVANS, A., CAMBOU, J., ARVEILER, D., Luc, G., BARD, J., BARA, L., RicARD, S., TIRET, L., AMOUYEL, P., ALHENC-GELAS, F. and SOUBRIER, F. 1992, Deletion polymorphism in the gene of angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 359, 641–643.
  • CANDY, G. P., SKTJDICKY, D., MTJELLER, U. K, WOODIWISS, A. J., SLIWA, K., LUKER, F., ESSER, J., SARELL P. and NORTON, G. R. 1999, Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. American Journal of Cardiology, 83, 740–744.
  • CARLUCCI°, M., SOCCIO, M. and DE CATERINA, R 2001, Aspects of gene polymorphisms in cardiovascular disease: the renin—angiotensin system. European Journal of Clinical Investigation, 31, 476–488.
  • CHEN, Y.-T., VACCARINO, V, WILLIAMS, C. S., BUTLER, J., BERKMAN, L. F. and KRUMHOLZ, H. M. 1999, Risk factors for heart failure in the elderly: a prospective community-based study. American Journal of Medicine, 106, 605–612.
  • COWIE, M., MOSTERD, A., WOOD, D., DECKERS, J., POOLE-WILSON, P., SUTTON, G. and GROBBEE, D. 1997, The epidemiology of heart failure. European Heart Journal, 18, 208–225.
  • COWIE, M., WOOD, D., COATS, A., THOMPSON, S., POOLE-WILSON, P., SURESTH, V. and SUTTON, V. 1999, Incidence and aetiology of heart failure. European Heart Journal, 20, 421–428.
  • DANSER, A. H. J., SCHALEKAMP, M. A. D. H., BAX, W. A., VAN DEN BRINK, A. M., SAXENA, P. R., RIEGGER, G. A. J. and SCHUNKERT, H. 1995, Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation, 92, 1387–1388.
  • DAVIES, M., Honns, F., DAVIS, R., KENKRE, J., ROALFE, A., HARE, R, WOSORNU, D. and LANCASHIRE, R 2001, Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardio-graphic Heart of England Screening study: a population based study. Lancet, 358, 439–444.
  • DAVIS, G. K, MILLNER, W. J. and ROBERTS, D. H. 2000, Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/deletion polymorphism and left ventricular function. European Journal of Heart Failure, 2 (3), 253–256.
  • DEI CAS, L., METRA, M., NODARI, S., Dm CAS, A. and GHEORGHIADE, M. 2003, Prevention and management of chronic heart failure in patients at risk. American Journal of Cardiology, 91 (9A), 10E–17F.
  • FISCHER, M., BAESSIER, A. and SCHUNKERT, H. 2002, Renin angiotensin system and gender differences in the cardiovascular system. Cardiovascular Research, 53, 672–677.
  • GALLAGHER, P. E., PING, L., LENHART, P., JOHN, R., CHAPPELL, M. and BROSNLHAN, K B. 1999, Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension, 33 (1S), 323–328.
  • JOHANSSON, S., WALLANDER, M. A., RUIGOMEZ, A., ALBERTO, L. and RODRIGUEZ, G. 2001, Incidence of newly diagnosed heart failure in UK general practice. European Journal of Heart Failure, 3, 225–231.
  • KANNEL, W. B. 2000, Vital epidemiologic clues in heart failure. Journal of Clinical Epidemiology, 53, 229–235.
  • KEAVNEY, B. 2002, Genetic epidemiological studies of coronary heart disease. International Journal of Epidemiology, 31, 730–736.
  • KEAVNEY, B., MCKENZIE, C., PARISH, S., PALMER, A., CLARK, S., YOUNGMAN, L., DELEPINE, M., LATHROP, M., PETO, R., COLLINS, R. and THE INTERNATIONAL STUDIES OF INFARCT SURVIVAL (ISIS) COLLABORATORS 2000, Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet, 355, 434–442.
  • KUZNETSOVA, T, STAESSEN, J. A., WANG, J. G., GASOWSKI, J., NIKITIN, Y., RYABLKOV, A. and FAGARD, R 2000, Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. Journal of Human Hypertension, 14 (7), 447–454.
  • LEVY, D., KENCHAIAH, S., LARSON, M. G., BENJAMIN, E. J., KUPKA, M. J., Ho, K. K. L, MURABITO, J. and VASAN, R S. 2002, Long term trends in the incidence of and survival with heart failure. New England Journal of Medicine, 347, 1397–1402.
  • LINDPAINTNER, K, PFEFFER, M., KREUTS, R., STAMPFER, M., GRODSTEIN, F., LA MOTTEM, F., BURING, J. and HENNEKENS, C. 1995, A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New England Journal of Medicine, 332, 706–711.
  • LINDPAINTNER, K, LEE, M., LARSON, M. G., RAO, V. S., PFEFFER, M. A., ORDOVAS, J. M., SCHAEFER, E. J., WILSON, A. F., WILSON, P. W. F., VASAN, R S., MYERS, R H. and LENTY, D. 1996, Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. New England Journal of Medicine, 334, 1023–1028.
  • MACINTYRE, K., CAPEWELL, S., STEWART, S., CHALMERS, J. W. T., FINLAYSON, A., REDPATH, A., PELL, J. P. and MCMURRAY, J. J. V. 2000, Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation, 102, 1126–1131.
  • MASOUDI, F. A., HAVRANEK, E. P., Smrni, G., FISH, R H., STEINER, J. F., ORDIN, D. L. and KRUMHOLZ, H. M. 2003, Gender, age, and heart failure with preserved left ventricular systolic function. Journal of the American College of Cardiology, 41, 217–223.
  • McKEE, P. A., CASTELLI, W. P., MCNAMARA, P. M. and KANNEL, W. B. 1971, The natural history of congestive heart failure. New England Journal of Medicine, 285, 1441–1446.
  • MONTGOMERY, H., KEELING, P., GOLDMAN, J., HUMPHRIES, S., TALMUD, P. and MCKENNA, W. 1995, Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 25, 1627–1631.
  • MOSTERD, A., HOES, A., DE BRUYNE, M., DECKERST, J., LINKER, D., HOFMAN, A. and GROBBEE, D. 1999, Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam study. European Heart Journal, 20, 447–455.
  • O'DONNELL, C.J., LINDPAINTNER, K, LARSON, M. G., RAO, V. S., ORDOVAS, J. M., SCHAEFER, E. J., MYERS, R. H. and LEVY, D. 1998, Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation, 97, 1766–1772.
  • OLIVARI, M. T. 2000, Behavioral and environmental factors contributing to the development and progression of congestive heart failure. Journal of Heart and Lung Transplantation, 19, 12–20.
  • RIGAT, B., HUBERT, C., ALHENC-GELAS, F., CAMBIEN, F., CORVOL, P. and SATJBRIER, F. 1990, An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum levels. Journal of Clinical Investigation, 86, 1343–1346.
  • REMME, W. J. and SWEDBERG, K. 2002, Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. European Journal of Heart Failure, 4, 11–22.
  • SAMANI, N., THOMPSON, J. R, faTooLE, L., CHANNER, K and WOODS, K L. 1996, A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation, 94, 708–712.
  • SCHUNKERT, H., HENSE, H.-W, HOLIVIER, S. R., STENDER, M., PERZ, S., Ken., U., LORELL, B. H. and RIEGGER, G. 1994, Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. New England Journal of Medicine, 330 (23), 1634–1638.
  • TIRET, L., MALLET, C., POIRIER, 0., NICAUD, V, MILLAIRE, A., BOUHOUR, J.-B., Roizts, G., DESNOS, M., DORENT, R, SCHWARTZ, K, CAMBIEN, F. and KomAJDA, M. 2000, Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 35, 29–35.
  • WILHELMSEN, L., ROSENGREN, A., ERIKSSON, H. and LAPPAS, G. 2001, Heart failure in the general population of men — morbidity, risk factors and prognosis. Journal of Internal Medicine, 249, 253–261.
  • ZANNAD, F., BRIANCON, S., JurmER, Y., MERTES, P., Vu T FMONT, J., ALI-A, F., VIRION, J. and THE EPICAL INVESTIGATORS 1999, Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Journal of the American College of Cardiology, 33, 734–742.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.